Patients would, therefore, benefit from treatment that is tailored to their disease subgroup, as well as other possible disease biomarkers, such as antibodies against cytoplasmic muscle proteins
On a call with investors Wednesday, David Moore, president of Novo Nordisk U.S., said early uptake of the Wegovy pill was more than twice that of any previous weight loss drug launch in the United States
It is important to watch for side effects
These research-stage amylin-based candidates differ in receptor focus, molecular design, clinical evidence, side-effect profile, and development strategy
Mo C, et al
Oz called this revolutionary fat-busting drug a true game changer